Description

7H-Spiro[Furo[3,4-B]Pyridine-5,3''-Pyrrolin]-7-One is a high-purity, advanced pharmaceutical intermediate characterized by its complex spirocyclic fused-ring structure. This compound is of significant commercial importance for enabling the synthesis of novel, biologically active molecules, particularly in medicinal chemistry research and development. It is primarily sought after by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the development of new therapeutic agents, including potential central nervous system (CNS) drugs and enzyme inhibitors.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel drug candidates targeting various disease pathways.
• Medicinal Chemistry Research: Used in lead optimization and structure-activity relationship (SAR) studies to develop new pharmacophores.
• Biologically Active Compound Synthesis: Serves as a core scaffold for creating molecules with potential activity against neurological disorders.
• Fine Chemical Production: Employed in the multi-step synthesis of complex, high-value specialty chemicals for the life sciences industry.
• Contract Research & Development (CRO/CMO): Supplied to organizations providing custom synthesis and process development services.
• Academic Research: Utilized in university and institutional labs for exploratory organic synthesis and chemical biology projects.

Basic Information

Product Name	7H-Spiro[Furo[3,4-B]Pyridine-5,3''-Pyrrolin]-7-One
CAS No.	869969-57-3
Molecular Formula	C13H10N2O2
Molecular Weight	226.23 g/mol
Synonyms	7H-Spiro[furo[3,4-b]pyridine-5,3'-pyrrolin]-7-one; 7H-Spiro(furo(3,4-b)pyridine-5,3'-pyrrolin)-7-one; 869969-57-3; Spiro[furo[3,4-b]pyridine-5,3'-pyrrolin]-7(1H)-one; 1H-Spiro[furo[3,4-b]pyridine-5,3'-pyrrolin]-7-one; Furo[3,4-b]pyridine spirocycle; 5,3'-Pyrrolin-furopyridinone spiro compound
EINECS	Contact for details

Quality Control

Our production of 7H-Spiro[Furo[3,4-B]Pyridine-5,3''-Pyrrolin]-7-One adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity, critical for sensitive pharmaceutical applications. All materials are fully characterized using advanced analytical techniques including NMR, HPLC, and MS. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with each shipment to support your regulatory and research documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). The compound may be light-sensitive; prolonged exposure to light should be avoided. Keep the container tightly sealed to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference standard
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Any single unknown impurity	≤ 1.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.